Company Ticker News September 25, 2021Why AbbVie Just Made a $1.8 Billion Gene Therapy Deal 0 0 Share
Company Ticker News September 25, 2021Takeda Guilty Of Supply Contract Breach With AbbVie For Prostate Cancer Drug 0 0 Share
Company Ticker News September 25, 2021AbbVie (ABBV) is a Top Dividend Stock Right Now: Should You Buy? 0 0 Share
Company Ticker News September 24, 2021Welcoming New Positions In AbbVie And VICI Properties 0 0 Share
Company Ticker News September 24, 20214.9% Yielding AbbVie Is The Best Buffett Aristocrat Bargain You Can Buy 0 0 Share
Company Ticker News September 22, 2021Hedge Funds Dump Stocks: Move to These 5 Big Dividend Winners Now 0 0 Share
Company Ticker News September 21, 2021AbbVie Is Worth 28% More Based on Impressive Dividends 0 0 Share
Company Ticker News September 21, 2021AbbVie (ABBV) Stock Moves -1.23%: What You Should Know 0 0 Share
Press Release September 20, 2021AbbVie Submits Regulatory Application to FDA for Risankizumab-rzaa (SKYRIZI®) for the Treatment of Patients 16 Years and Older with Moderate to Severe Crohn's Disease 0 0 Share
